— Know what they know.
Not Investment Advice

AMRN NASDAQ

Amarin Corporation plc
1W: -6.4% 1M: -9.8% 3M: -21.5% YTD: -10.0% 1Y: -25.8% 3Y: -32.6% 5Y: -88.6%
$12.35
-0.37 (-2.91%)
 
Weekly Expected Move ±3.9%
$11 $12 $12 $13 $13
NASDAQ · Healthcare · Drug Manufacturers - General · Tech Score Strong Sell · Power 28 · $255.4M mcap · 21M float · 0.359% daily turnover · Short 38% of daily vol

Balance Sheet Trends

Total Assets
$671M -2.1% ▼
5Y CAGR: -7.0%
Total Liabilities
$211M +6.2% ▲
5Y CAGR: -9.0%
Shareholders Equity
$459M -5.5% ▼
5Y CAGR: -6.1%
Cash & Investments
$303M +2.9% ▲
5Y CAGR: -9.6%
Total Debt
$12M +57.5% ▲
5Y CAGR: +5.8%
Net Debt
-$123M -8.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$219M$218M$199M$121M$135M
Short-Term Investments$235M$92M$121M$173M$168M
Cash & ST Investments$454M$309M$321M$294M$303M
Net Receivables$164M$131M$134M$122M$127M
Inventory$235M$229M$259M$166M$196M
Other Current Assets$4M$20M$525K$13M$24M
Total Current Assets$879M$689M$725M$595M$650M
Property, Plant & Equip.$9M$10M$8M$8M$6M
Goodwill & Intangibles$24M$22M$19M$16M$13M
Long-Term Investments$35M$1M$0$0$0
Other Non-Current Assets$122M$164M$79M$66M$1M
Total Non-Current Assets$189M$197M$107M$90M$21M
Total Assets$1.1B$886M$832M$685M$671M
— Liabilities —
Accounts Payable$115M$65M$53M$40M$45M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$3M$2M$2M$0$0
Other Current Liabilities$46M$36M$185M$140M$149M
Total Current Liabilities$371M$259M$259M$180M$194M
Long-Term Debt$0$0$0$0$6M
Other Non-Current Liab.$8M$8M$9M$12M$5M
Total Non-Current Liabilities$30M$31M$20M$19M$17M
Total Liabilities$401M$291M$280M$199M$211M
— Equity —
Common Stock$294M$299M$303M$305M$310M
Retained Earnings-$1.4B-$1.5B-$1.6B-$1.7B-$1.7B
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$667M$595M$552M$486M$459M
Total Liabilities & Equity$1.1B$886M$832M$685M$671M
— Key Metrics —
Total Debt$9M$10M$9M$8M$12M
Net Debt-$211M-$208M-$191M-$113M-$123M
Total Investments$270M$93M$121M$173M$168M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms